Literature DB >> 12720476

Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals?

Gary S Sachs1, A John Rush.   

Abstract

Bipolar disorder presents particular challenges with regard to assessing response to therapy. Criteria for determining remission and recovery have been suggested for mood disorders, but the clinical usefulness of these terms in bipolar disorder is elusive. Formal psychological rating scales may be impractical in a routine medical practice setting. As an alternative, clinicians might probe for information about particular "signal events," such as sleep disturbances, that may herald mood fluctuations. The ultimate goal of bipolar management should be complete and sustained remission, whenever possible, although most patients will not achieve this status for any significant length of time. Furthermore, overaggressive management might entail pushing medication doses to intolerable levels. Individual treatment goals should always take into account patient acceptance of side effect burden, allowing for trade-offs between treatment effect and quality of life. Noncompliance with therapy, notoriously common among patients suffering from bipolar disorder, can stem from drug side effects, treatment ineffectiveness, or even treatment success if the patient misses the manic symptoms. Despite effective treatment, relapse is common. Realistic treatment goals should strive for sustained symptom abatement while maximizing patient quality of life from visit to visit.

Entities:  

Mesh:

Year:  2003        PMID: 12720476

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  13 in total

Review 1.  Polytherapy in bipolar disorder.

Authors:  Daniel Lin; Hiram Mok; Lakshmi N Yatham
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Bipolar disorder and quality of life: a patient-centered perspective.

Authors:  Erin E Michalak; Lakshmi N Yatham; Sharlene Kolesar; Raymond W Lam
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

3.  "I really don't know whether it is still there": ambivalent acceptance of a diagnosis of bipolar disorder.

Authors:  Maree L Inder; Marie T Crowe; Peter R Joyce; Stephanie Moor; Janet D Carter; Sue E Luty
Journal:  Psychiatr Q       Date:  2010-06

Review 4.  Pharmacological treatment of bipolar depression: qualitative systematic review of double-blind randomized clinical trials.

Authors:  Lucas Spanemberg; Raffael Massuda; Lucas Lovato; Leonardo Paim; Edgar Arrua Vares; Neusa Sica da Rocha; Keila Maria Mendes Ceresér
Journal:  Psychiatr Q       Date:  2012-06

5.  Assessment Tools for Adult Bipolar Disorder.

Authors:  Christopher J Miller; Sheri L Johnson; Lori Eisner
Journal:  Clin Psychol (New York)       Date:  2009-06-01

6.  The 'new normal': relativity of quality of life judgments in individuals with bipolar disorder-a qualitative study.

Authors:  Emma Morton; Erin Michalak; Rachelle Hole; Simone Buzwell; Greg Murray
Journal:  Qual Life Res       Date:  2018-02-12       Impact factor: 4.147

7.  Optimizing Adherence: Bipolar Disorder and the Therapeutic Motivational Alliance.

Authors:  Dorothy E Stubbe
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-07-16

8.  Quality of life in Iranian patients with bipolar disorder: a psychometric study of the Persian Brief Quality of Life in Bipolar Disorder (QoL.BD).

Authors:  Amirhossein Modabbernia; Mohammadhossein Yaghoubidoust; Chung-Ying Lin; Bengt Fridlund; Erin E Michalak; Greg Murray; Amir H Pakpour
Journal:  Qual Life Res       Date:  2015-12-29       Impact factor: 4.147

9.  Emotion perception and quality of life in bipolar I disorder.

Authors:  Daniel Fulford; Andrew D Peckham; Kaja Johnson; Sheri L Johnson
Journal:  J Affect Disord       Date:  2013-09-07       Impact factor: 4.839

Review 10.  The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?

Authors:  Isabella Soreca; Ellen Frank; David J Kupfer
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.